Trusted by over 1 million members
Try Scribd FREE for 30 days to access over 125 million titles without ads or interruptions! Start Free Trial Cancel Anytime.
Trusted by over 1 million members
Try Scribd FREE for 30 days to access over 125 million titles without ads or interruptions! Start Free Trial Cancel Anytime.
Trusted by over 1 million members
Try Scribd FREE for 30 days to access over 125 million titles without ads or interruptions! Start Free Trial Cancel Anytime.
Jorge Buys DL y col.
49. Cook JR, Dehner LP, LP, Collins MH, Ma Z, et al. Anaplastic lymphoma kinase (ALK) expression in the inammatory myomyo broblastic tumor: a comparative immunohistochemical study. Am J Surg Pathol 2001;25:1364-71. 50. Chan JK, Cheuk W, W, Shimizu M. Anaplastic lymphoma kinase expression in inammatory pseudotumors. Am J Surg Pathol 2001;25:761-8. 51. Tsujimoto Y, Y, Finger LR, Yunis J, Nowell PC, Croce CM. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Cloning of the chromoso me breakpoint of neoplastic B cells with the t(14;18) chromochromo some translocation. Science 1984;226(4678):1097-9. 52. Verma YK, Gangenahalli Gangenahalli GU, Singh VK, Gupta P, et al. Cell death regulation by B-cell lymphoma protein. Apoptosis 2006;11:459-71. 53. Bende RJ, Smit LA, van Noesel CJ. Molecular pathways in follicular lymphoma. Leukemia 2007;21:18-29. 54. Coelho Siqueira SA, Ferreira Alves VA, Beitler B, Otta MM, Nascimento Saldiva PH. Contribution of immunohistochemistry to small B-cell lymphoma classication. Appl ImmunohistoImmunohisto chem Mol Morphol 2006;14:1-6. 55. De Jong D, Rosenwald A, Chhanabhai M, Gaulard P, P, et al. Lymphoma Biomarker Consortium. Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical appli cations-a study from the Lunenburg Lymphoma Biomarker Consortium. J Clin Oncol 2007;25:805-12. 56. Capello D, Gaidano G. Molecular pathophysiology pathophysiology of indolent
adenocarcinoma. Am J Surg Pathol 2002;26:206-15. 66. Virchow R. Lecture XVII. Amyloid degeneration. degeneration. Inammation. Inammation. In: Cellular Pathology as Based Upon Physiological and Patho logical Histology. New York: Dover Publications, 1971;pp:40937. 67. Kebbel A, Rocken C. Immunohistochemical classication of amyloid in surgical pathology revisited. Am J Surg Pathol 2006;30:673-83. 68. Skinner M, Pepys MB, Cohen AS, Heller LM, Lian JB. Amyloid and Amyloidosis. Eds: Glenner GG, Pi nho e Costa P, Falcao de Freitas F. Amsterdam: Excerpta Medica, 1980;pp:384-91. 69. Tennent GA, Lovat LB, Pepys MB. Serum Amyloid P compocomponent prevents proteolysis of the amyloid brils of Alzheimer’s disease and systemic amyloidosis. Proc Natl Acad Sci USA 1995;92:4299-303. 70. Isobe T, T, Matsushita T, T, Minakata T, T, et al. Coexistence of AL and Ab2M amyloid in tissues of a patient with myeloma on hemodialysis. Amyloid 1996;3:41-43. 71. Liepnieks JJ, Benson MD. Codeposition of transthyretin and immunoglobulin lambda light chain in senile cardiac (ATTR) amyloidosis. In: Grateau G, Kyle R, Skinner M, eds. Amyloid and Amyloidosis. London: CRC Press, 2005;pp:332-33. 72. Störkel S, Stürer A. Combined amyloidosis of the AA and AB type following chronic hemodialysis. Pathologe 1989;10:10713. 73. Leong A SY. SY. Pitfalls in diagnostic immunohistology. Adv Anat Pathol 2004; 11:86-93. 11:86-93. 74. Cruz Spano L, Merçon de Vargas PR, Gagliardi Leite JP,
Trusted by over 1 million members
Try Scribd FREE for 30 days to access over 125 million titles without ads or interruptions! Start Free Trial Cancel Anytime.
Trusted by over 1 million members
Try Scribd FREE for 30 days to access over 125 million titles without ads or interruptions! Start Free Trial Cancel Anytime.
Trusted by over 1 million members
Try Scribd FREE for 30 days to access over 125 million titles without ads or interruptions! Start Free Trial Cancel Anytime.
Jorge Buys DL y col.
49. Cook JR, Dehner LP, LP, Collins MH, Ma Z, et al. Anaplastic lymphoma kinase (ALK) expression in the inammatory myomyo broblastic tumor: a comparative immunohistochemical study. Am J Surg Pathol 2001;25:1364-71. 50. Chan JK, Cheuk W, W, Shimizu M. Anaplastic lymphoma kinase expression in inammatory pseudotumors. Am J Surg Pathol 2001;25:761-8. 51. Tsujimoto Y, Y, Finger LR, Yunis J, Nowell PC, Croce CM. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Cloning of the chromoso me breakpoint of neoplastic B cells with the t(14;18) chromochromo some translocation. Science 1984;226(4678):1097-9. 52. Verma YK, Gangenahalli Gangenahalli GU, Singh VK, Gupta P, et al. Cell death regulation by B-cell lymphoma protein. Apoptosis 2006;11:459-71. 53. Bende RJ, Smit LA, van Noesel CJ. Molecular pathways in follicular lymphoma. Leukemia 2007;21:18-29. 54. Coelho Siqueira SA, Ferreira Alves VA, Beitler B, Otta MM, Nascimento Saldiva PH. Contribution of immunohistochemistry to small B-cell lymphoma classication. Appl ImmunohistoImmunohisto chem Mol Morphol 2006;14:1-6. 55. De Jong D, Rosenwald A, Chhanabhai M, Gaulard P, P, et al. Lymphoma Biomarker Consortium. Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical appli cations-a study from the Lunenburg Lymphoma Biomarker Consortium. J Clin Oncol 2007;25:805-12. 56. Capello D, Gaidano G. Molecular pathophysiology pathophysiology of indolent
adenocarcinoma. Am J Surg Pathol 2002;26:206-15. 66. Virchow R. Lecture XVII. Amyloid degeneration. degeneration. Inammation. Inammation. In: Cellular Pathology as Based Upon Physiological and Patho logical Histology. New York: Dover Publications, 1971;pp:40937. 67. Kebbel A, Rocken C. Immunohistochemical classication of amyloid in surgical pathology revisited. Am J Surg Pathol 2006;30:673-83. 68. Skinner M, Pepys MB, Cohen AS, Heller LM, Lian JB. Amyloid and Amyloidosis. Eds: Glenner GG, Pi nho e Costa P, Falcao de Freitas F. Amsterdam: Excerpta Medica, 1980;pp:384-91. 69. Tennent GA, Lovat LB, Pepys MB. Serum Amyloid P compocomponent prevents proteolysis of the amyloid brils of Alzheimer’s disease and systemic amyloidosis. Proc Natl Acad Sci USA 1995;92:4299-303. 70. Isobe T, T, Matsushita T, T, Minakata T, T, et al. Coexistence of AL and Ab2M amyloid in tissues of a patient with myeloma on hemodialysis. Amyloid 1996;3:41-43. 71. Liepnieks JJ, Benson MD. Codeposition of transthyretin and immunoglobulin lambda light chain in senile cardiac (ATTR) amyloidosis. In: Grateau G, Kyle R, Skinner M, eds. Amyloid and Amyloidosis. London: CRC Press, 2005;pp:332-33. 72. Störkel S, Stürer A. Combined amyloidosis of the AA and AB type following chronic hemodialysis. Pathologe 1989;10:10713. 73. Leong A SY. SY. Pitfalls in diagnostic immunohistology. Adv Anat Pathol 2004; 11:86-93. 11:86-93. 74. Cruz Spano L, Merçon de Vargas PR, Gagliardi Leite JP,
